Kleiner Perkins Caufield & BYERS Xiii, LLC, 10% Owner at Epizyme, Inc. (EPZM), sold 388,584 shares at $27.64 ($10.7M) on 2014-02-10, disclosed to the SEC on 2014-02-12.
Open-market sale of $10.7M EPZM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.